NAMPT and ovarian carcinoma: Given that NAD+ levels are elevated in cancer cells compared with non-malignant cells due to upregulated NAD+ biosynthesis [45], we report high NAMPT expression is associated with poor outcomes in ovarian cancers in TCGA data.